wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q58770545-01D8D05C-766A-43E1-B8BC-8E91E1AE91A5
Q58770545-01D8D05C-766A-43E1-B8BC-8E91E1AE91A5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58770545-01D8D05C-766A-43E1-B8BC-8E91E1AE91A5
MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma
P2860
Q58770545-01D8D05C-766A-43E1-B8BC-8E91E1AE91A5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58770545-01D8D05C-766A-43E1-B8BC-8E91E1AE91A5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c350d82e2c80b01fd99c81d221181d8bbfd5e2e1
P2860
Efficacy of bortezomib in sarcomas with high levels of MAP17 (PDZK1IP1).